Acme Pharma-Xylonex Sources-Experts-Patients for New York Times

The story focuses on ongoing developments and controversies related to the pharmaceutical company Acme Pharma and their recently launched drug Xylonex. The journalist is seeking information and firsthand accounts from current or former employees, industry experts, or patients familiar with Acme Pharma's operations, drug trials, and regulatory interactions. If you have any insights, documents, or experiences related to Acme Pharma or the Xylonex drug trials, please get in touch to share your information.